References
- JagerRDMielerWFMillerJWAge-related macular degenerationN Engl J Med2008358242606261718550876
- OshimaYIshibashiTMurataTTaharaYKiyoharaYKubotaTPrevalence of age related maculopathy in a representative Japanese population: the Hisayama studyBr J Ophthalmol200185101153115711567955
- MitchellJBradleyCQuality of life in age-related macular degeneration: a review of the literatureHealth Qual Life Outcomes200649717184527
- FriedmanDSO’ColmainBJMuñozBEye Disease Prevalence Research GroupPrevalence of age-related macular degeneration in the United StatesArch Ophthalmol2004122456457215078675
- AMD Alliance InternationalThe Global Economic Cost of Visual Impairment: Summary Report2010 Available from: http://www.amdalliance.org/amdalliance/AMDAlliance/cost-of-blindnessAccessed May 20, 2013
- BrownGCBrownMMSharmaSThe burden of age-related macular degeneration: a value-based medicine analysisTrans Am Ophthalmol Soc2005103173184 discussion 184–18617057801
- YasudaMKiyoharaYHataYNine-year incidence and risk factors for age-related macular degeneration in a defined Japanese population the Hisayama studyOphthalmology2009116112135214019744734
- RobertsCBHiratsukaYYamadaMEconomic cost of visual impairment in JapanArch Ophthalmol2010128676677120547955
- WooJHAu EongKGDon’t lose sight of age-related macular degeneration: the need for increased awareness in SingaporeSingapore Med J2008491185085319037547
- ChenSJChengCYPengKLPrevalence and associated risk factors of age-related macular degeneration in an elderly Chinese population in Taiwan: the Shihpai Eye StudyInvest Ophthalmol Vis Sci20084973126313318390643
- World Health OrganizationWHOQOL: Measuring quality of life1997 Available from: http://www.who.int/mental_health/media/68.pdfAccessed May 20, 2013
- SteinJDBrownMMBrownGCHollandsHSharmaSQuality of life with macular degeneration: perceptions of patients, clinicians, and community membersBr J Ophthalmol200387181212488253
- BresslerNMChangTSFineJTDolanCMWardJAnti-VEGF Antibody for the Treatment of Predominantly Classic Choroidal Neovascularization in Age-Related Macular Degeneration (ANCHOR) Research GroupImproved vision-related function after ranibizumab vs photodynamic therapy: a randomized clinical trialArch Ophthalmol20091271132119139332
- ChangTSBresslerNMFineJTImproved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trialArch Ophthalmol2007125111460146917998507
- SuzukamoYOshikaTYuzawaMPsychometric properties of the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25), Japanese versionHealth Qual Life Outcomes200536516248900
- MiskalaPHBassEBBresslerNMSubmacular Surgery Trials (SST) Research GroupSurgery for subfoveal choroidal neovascularization in age-related macular degeneration: quality-of-life findings: SST report no 12Ophthalmology2004111111981199215522363
- MarellaMPesudovsKKeeffeJEO’ConnorPMReesGLamoureuxELThe psychometric validity of the NEI VFQ-25 for use in a low-vision populationInvest Ophthalmol Vis Sci20105162878288420089878
- OrrPRentzAMMargolisMKValidation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in age-related macular degenerationInvest Ophthalmol Vis Sci20115263354335921282568
- Age-Related Eye Disease Study Research GroupThe Age-Related Eye Disease Study (AREDS): design implications. AREDS report no 1Control Clin Trials199920657360010588299
- LindbladASClemonsTEResponsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS Report no 14Arch Ophthalmol200512391207121416157800
- SuñerIJKokameGTYuEWardJDolanCBresslerNMResponsiveness of NEI VFQ-25 to changes in visual acuity in neovas-cular AMD: validation studies from two phase 3 clinical trialsInvest Ophthalmol Vis Sci20095083629363519255158
- McClureMEHartPMJacksonAJStevensonMRChakravarthyUMacular degeneration: do conventional measurements of impaired visual function equate with visual disability?Br J Ophthalmol200084324425010684832
- SchmierJKHalpernMTCovertDValidation of the Daily Living Tasks Dependent on Vision (DLTV) questionnaire in a U S population with age-related macular degenerationOphthalmic Epidemiol200613213714316581618
- GlobeDRLevinSChangTSMackenziePJAzenSValidity of the SF-12 quality of life instrument in patients with retinal diseasesOphthalmology2002109101793179812359596
- HeierJSBrownDMChongVVIEW 1 and VIEW 2 Study GroupsIntravitreal aflibercept (VEGF trap-eye) in wet age-related macular degenerationOphthalmology2012119122537254823084240
- LeysAZlatevaGShahSNPatelMQuality of life in patients with age-related macular degeneration: results from the VISION studyEye (Lond)200822679279817585313
- ChanCWWongDLamCLMcGheeSLaiWWDevelopment of a Chinese version of the National Eye Institute Visual Function Questionnaire (CHI-VFQ-25) as a tool to study patients with eye diseases in Hong KongBr J Ophthalmol200993111431143619515645
- LabirisGKatsanosAFanariotisMPsychometric properties of the Greek version of the NEI-VFQ 25BMC Ophthalmol20088418325083
- OkudaMOhkuboKGotoMComparative study of two Japanese rhinoconjunctivitis quality-of-life questionnairesActa Otolaryngol2005125773674416012036
- OkuboKKuronoYFujiedaSJapanese Society of AllergologyJapanese guideline for allergic rhinitisAllergol Int201160217118921636965